No headlines found.
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 10-Jan 5:00 PM ET)
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
Globe Newswire (Fri, 10-Jan 8:00 AM ET)
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Globe Newswire (Thu, 7-Nov 7:00 AM ET)
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Axogen trades on the NASDAQ stock market under the symbol AXGN.
As of January 29, 2025, AXGN stock price declined to $18.31 with 224,757 million shares trading.
AXGN has a beta of 0.51, meaning it tends to be less sensitive to market movements. AXGN has a correlation of 0.01 to the broad based SPY ETF.
AXGN has a market cap of $805.79 million. This is considered a Small Cap stock.
Last quarter Axogen reported $49 million in Revenue and $.07 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.06.
In the last 3 years, AXGN traded as high as $19.06 and as low as $3.45.
The top ETF exchange traded funds that AXGN belongs to (by Net Assets): VTI, IWM, VXF, IWO, FESM.
AXGN has outperformed the market in the last year with a return of +92.1%, while the SPY ETF gained +24.9%. In the last 3 month period, AXGN beat the market returning +31.3%, while SPY returned +4.0%. However, in the most recent 2 weeks AXGN has underperformed the stock market by returning +0.4%, while SPY returned +3.4%.
AXGN support price is $17.62 and resistance is $19.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AXGN shares will trade within this expected range on the day.